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ABSTRACT
A healthy 25-year-old crewmember of a navy ship was diagnosed with suspected pneumonia and prescribed 
100 mg twice a day of doxycycline for 10 days. During the 7th day of treatment the patient joined his navy 
ship to sail aboard and 2 days later, immediately after taking the doxycycline capsule, he felt a forceful pain in 
the median chest which was followed with odynophagia of both solid foods and liquids. The patient adhered 
to the administration guidelines of the doxycycline, except drinking 330 mL of beer, 3 h before taking the 
capsule. A working diagnosis of atypical chest pain, possibly due to oesophagitis, was made. The patient 
was advised to fast and rest and treatment with intravenously (IV) H2-receptor antagonist, clear fluids and 
analgesics was started. Later on, due to lack of improvement in the patient’s status and the potential risk 
of future deterioration, a decision was made to evacuate the patient to a hospital. Gastroscopy, revealed 
3 ulcers in the mid-oesophagus and the patient was hospitalised for treated of IV antacids and fluids with 
gradual improvement. This case emphasizes the limitation of diagnosing and treating a common side effect 
in the middle of the sea and the potential risk in taking medications with alcohol.
(Int Marit Health 2015; 66, 3: 181–183)
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INTRODUCTION
Doxycycline is a common cause of drug induced oesoph-
ageal ulcers. Improper advice or inaccurate instructions re-
garding drug ingestion are the main risk factors. We present 
a 25-year-old crewmember on a navy ship developing ulcer-
ating oesophagitis following doxycycline ingestion despite 
adherence to the administration guidelines of the drug. 
PATIENT DESCRIPTION
A 25-year-old fit and healthy crewmember of a navy 
ship, without any prior medical history, presented at the 
unit’s medical clinic complaining of 5 days of fever and 
cough without dyspnoea, chest pain or other complaints. 
Vital signs were normal, but auscultation revealed crackles 
and rhonchi throughout the lung fields. He was prescribed 
100 mg twice a day of doxycycline for 10 days as empir-
ic treatment for a suspected pneumonia. The physician 
instructed the patient to administer the doxycycline with 
a glass of water and to sit up for at least 30 min after 
taking the capsule. He ordered additional lab work in-
cluding chest X-ray and blood tests that were done by the 
4th day of treatment and revealed no abnormalities. The 
next day, the physician called the patient, who described 
a significant improvement under the treatment, and so, 
was instructed to complete the course of antibiotics, based 
on his symptoms and the fact that lab work might not show 
abnormalities in atypical pneumonia.
During the 7th day of treatment the patient joined his 
navy ship to sail aboard. Before sailing the patient reported 
that he felt excellent, and his vital signs were unremarkable.
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During the 9th night of treatment, about 5 min after tak-
ing the doxycycline capsule, the patient felt a forceful pain 
in the median chest. The pain was sharp, with no radiation 
and no associated symptoms. The patient drank another 
glass of water and the pain subsided.
The following morning, the patient met the ship’s physi-
cian and reported his symptoms. He described a constant 
strong and sharp pain located at the retrosternal area and 
odynophagia rated as 8/10 on a verbal pain scale (0 repre-
senting no pain at all). Swallowing of both solid foods and 
liquids aggravated the pain, although the patient denied 
any dysphagia, dyspnoea, sweating, palpitations, nausea 
or vomiting. The patient had not experienced pain of this 
nature in the past. Prior to the pain he felt excellent, did not 
smoke or perform any physical exercises. He noted that 3 h 
before taking the capsule he drank about 330 mL of beer. 
Otherwise he adhered to the administration guidelines of 
the doxycycline, as he was ordered.
On physical examination, the blood pressure was 
124/82 mm Hg on the right side and 128/83 mm Hg on 
the left side, the pulse was 84 bpm. The oxygen saturation 
was 97% and the temperature was 36.4°C. His lungs were 
clear to auscultation bilaterally and the electrocardiogram 
was normal. 
A working diagnosis of atypical chest pain, possibly 
due to oesophagitis, was made. The patient was advised 
to fast and rest. Intravenously (IV) H2-receptor antagonist 
(ranitidine hydrochloride, 50 mg) and clear fluids (compound 
sodium lactate — Hartmann’s solution) were administered 
along with per os (PO) metamizole drops for the pain, which 
resolved gradually. 
The next day the patient felt better and managed to eat 
some ice cream; however, all other ingestion of foods or liq-
uids was followed by strong, sharp chest pain. There were no 
abdominal symptoms, no melena or visible blood in the faeces.
Four days after the initial symptoms started, the patient 
complained of increasing pain and weakness. After consul-
tation with the ship’s captain and a land based gastroenter-
ologist, due to lack of improvement in the patient’s status 
and the potential risk of future oesophageal perforation 
during the expected journey duration, a decision was made 
to evacuate the patient to a hospital. 
On admission to the emergency department that eve-
ning, his blood pressure was 117/83 mm Hg, his pulse was 
74 bpm, oxygen saturation 97% in room air, respiratory rate 
was 12 breaths per minute and there was no fever. Phys-
ical examination was unremarkable and complete blood 
count showed no anaemia. He was hospitalised in order to 
administer IV treatment of antacids and fluids and perform 
gastroscopy.
Gastroscopy, revealed 3 ulcers in the mid-oesophagus 
(25–30 cm from the dental line). The largest was 8 × 3 mm 
without active bleeding. In addition, mild antral gastritis 
and bulbar duodenitis were found. Biopsies showed se-
vere active ulcerating oesophagitis and moderate chronic 
antral gastritis and tested negative for Helicobacter pylori, 
Cytomegalovirus, Herpes virus and fungi, supporting the sus-
pected diagnosis of doxycycline induced ulcerating oesoph-
agitis. The patient was hospitalised for 6 days and treated 
with IV esomeprazole sodium. After gradual improvement 
in his ability to swallow solid food, he was discharged with 
recommendations for further treatment with PO proton 
pump inhibitors.
Follow up gastroscopy after a month showed complete 
healing of the mucosa and no other abnormal findings. 
Written informed consent was obtained from the patient 
for publication of this case report. 
DISCUSSION
Medication-induced oesophagitis or “pill oesophagitis” 
can be caused by various mechanisms and medications, 
including: anti-inflammatories, bisphosphonates, potassium 
chloride, antibiotics and many more. Tetracycline and its 
variant, doxycycline, are consider as frequent causes and 
are found to be responsible for more than 50% of cases [1], 
although this side effect is reported in the drugs’ information 
in less than 1% of patients taking the capsule.
Medication guidelines, instructing patients to take doxy-
cycline capsules with (at least) 100 mL water, remain upright 
and not take the treatment before going to bed. Withdrawal 
of doxycycline and investigation of oesophageal disorder 
should be considered if symptoms such as dyspepsia or 
retrosternal pain occur. Caution is required in the treatment 
of patients with known oesophageal reflux disorders.
The injury frequently occurs at narrow segments of the 
oesophagus such as in the mid-oesophagus region about 
25 cm from the incisors where the oesophagus passes 
behind the aortic arch and the left bronchus, resulting in 
decreasing the oesophageal peristaltic wave [2]. The injury 
mechanism is probably due to local acid burn, as doxycycline 
has a pH less than 3 when dissolved in distilled water or 
saliva [3]. There are several known risk factors including: 
supine position, large size of the pill, the amount of fluid 
ingested with the medication, oesophageal motility disor-
ders and anatomical or pathological strictures (e.g. atrial 
enlargement) [4]. 
Symptoms can develop between a few hours and 10 
days and include odynophagia (94%), heartburn (80%) dys-
phagia (54%), and rarely, haematemesis, abdominal pain, 
and weight loss [5, 6].
Diagnosis can be made by history alone or by endosco-
py, which is recommended when severe clinical symptoms 
occur to assure the diagnosis, evaluate the injury, and 
provide local treatment if needed. The common endoscopic 
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findings associated with doxycycline are mid-oesophageal 
ulcers [7, 8], with biopsy usually showing nonspecific acute 
inflammatory changes.
Treatment is mainly supportive and includes discon-
tinuation of the medication if possible, and using liquid 
formulas if available. 
Anti-acid treatment is frequently used and recommend-
ed, although its’ efficacy has never been established. In 
severe cases, nothing per mouth and parenteral fluids are 
needed and endoscopic intervention for severe mucosal 
injury.
 Although symptoms are relieved within 1 week in the 
majority of patients, complete resolution of the ulcers lasts 
up to 5 weeks. Complications such as perforation are very 
rare [5]. 
Medication-induced oesophagitis, although a known 
adverse effect of many drugs and especially specific an-
tibiotics, is considered a rare complication and possibly 
preventable by adherence to administration’s recommen-
dations. In this case we described almost classic presenta-
tion of pill oesophagitis due to doxycycline. However a few 
interesting facts makes this case unusual.
The patient took doxycycline for 8 days without any side 
effects. The symptoms occurred on the 9th day although he 
ingested the capsule with a glass of water. The fact that the 
patient had ingested an alcoholic beverage 3 h before tak-
ing the capsule may have contributed to the disruption, as 
alcohol causes transient decrease in the lower oesophageal 
sphincter pressure and inhibition of the primary peristaltic 
movement of the distal oesophagus body leading to im-
paired oesophageal clearance [9]. Alcohols have well known 
harmful interactions with medications, and may cause nu-
merous medical symptoms. It may increase the risk of long 
term complications such as: liver damage, heart problems 
and internal bleeding. In some cases, alcohol interactions 
may decrease the effectiveness of medications or lead to 
drug toxicity [10]. In this case, it might be less possible that 
a small amount of beer 3 h prior taking the capsule had 
a significant adverse effect. However, it is vital to explain the 
patient the importance of avoiding it with any medications 
he takes — as even a minor amount of alcohol consumption 
can increase the risk for major complications.
CONCLUSIONS
Doxycycline is one of the most common drugs causing 
oesophagitis. The injury frequently occurs at mid-oesoph-
ageal area and the injury mechanism is probably due to 
local acid burn. Symptoms usually include odynophagia 
and heartburn and the treatment is mainly supportive and 
includes discontinuation of the medication if possible and 
anti-acid drugs. The symptoms are relieved within 1 week 
in the majority of patients, but complete resolution of the 
ulcers lasts up to 5 weeks. Complications such as perfora-
tion are very rare. 
Medical emergencies on an isolate ship can create 
challenging situations. The limited medical equipment and 
diagnostic capabilities create a complicated situation for 
the maritime physician that requires him to be alert and 
be resourceful, in order to prevent complications and de-
terioration.
This case emphasizes the limitation of diagnosing and 
treating a common side effect that might deteriorate fast 
into a life threatening situation in the middle of the sea. 
Moreover, this case highlights the potential risk in taking 
medications with alcohol as it may influence the course of 
many drugs and especially antibiotics. 
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